France Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

The Best Way to Manage your Money. Start using Mint today to set a budget, track your goals and do more with your money. From our sponsors

France Pharmaceuticals and Healthcare Report Q4 2013 Oct 2nd 2013, 00:00, by swapnil BMI View: We expect pressures on the French government to mount over the coming quarters encouraging it to engage in more concerted fiscal consolidation, particularly as lower growth begins to translate into lower government revenues. We believe that the pharmaceuticals and healthcare sector, which is a recipient of a large proportion of public funds, will be a target of the government’s cost containment efforts. While France has not fallen prey to the bond vigilantes thus far, unlike the peripheral countries of the eurozone, the country nonetheless has one of the largest public sector debt piles in Europe and remains susceptible … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118139. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/france-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions